Luna Kaduri

907 total citations
13 papers, 656 citations indexed

About

Luna Kaduri is a scholar working on Genetics, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luna Kaduri has authored 13 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luna Kaduri's work include BRCA gene mutations in cancer (8 papers), Cancer Genomics and Diagnostics (5 papers) and Advanced Breast Cancer Therapies (3 papers). Luna Kaduri is often cited by papers focused on BRCA gene mutations in cancer (8 papers), Cancer Genomics and Diagnostics (5 papers) and Advanced Breast Cancer Therapies (3 papers). Luna Kaduri collaborates with scholars based in Israel, United States and Sweden. Luna Kaduri's co-authors include Tamar Peretz, Joël Zlotogora, Israela Lerer, Dvorah Abeliovich, Norman Heching, N. Weinberg, G Amir, M. Sagi, Ora Paltiel and Malka Avitzour and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and British Journal of Cancer.

In The Last Decade

Luna Kaduri

13 papers receiving 628 citations

Peers

Luna Kaduri
L. Digianni United States
Sani Malami Nigeria
Joanne McKinley Australia
Jessica Clague United States
Z. Kerestes Australia
L. Digianni United States
Luna Kaduri
Citations per year, relative to Luna Kaduri Luna Kaduri (= 1×) peers L. Digianni

Countries citing papers authored by Luna Kaduri

Since Specialization
Citations

This map shows the geographic impact of Luna Kaduri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luna Kaduri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luna Kaduri more than expected).

Fields of papers citing papers by Luna Kaduri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luna Kaduri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luna Kaduri. The network helps show where Luna Kaduri may publish in the future.

Co-authorship network of co-authors of Luna Kaduri

This figure shows the co-authorship network connecting the top 25 collaborators of Luna Kaduri. A scholar is included among the top collaborators of Luna Kaduri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luna Kaduri. Luna Kaduri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Rosenberg, Shai, Luna Kaduri, Albert Grinshpun, et al.. (2023). Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status. Breast Cancer Research and Treatment. 198(2). 197–205. 1 indexed citations
2.
Yerushalmi, Rinat, Shani Paluch–Shimon, Frederick L. Baehner, et al.. (2022). 152P Molecular characterization by the 21-gene breast cancer (BC) Recurrence Score (RS) test of BRCA1/2 mutation carriers (mBRCA1/2) versus the general BC patient (pt) population. Annals of Oncology. 33. S609–S609. 1 indexed citations
3.
Kaduri, Luna, et al.. (2016). Utilizing fluorescent life time imaging microscopy technology for identify carriers of BRCA2 mutation. Biochemical and Biophysical Research Communications. 480(1). 36–41. 9 indexed citations
4.
Goldberg, Yael, Inbal Kedar, Naama Halpern, et al.. (2013). Lynch Syndrome in high risk Ashkenazi Jews in Israel. Familial Cancer. 13(1). 65–73. 16 indexed citations
5.
Kaduri, Luna, et al.. (2010). Relationship Between Severity of Symptoms and Quality of Life in Patients With Breast Cancer Receiving Adjuvant Hormonal Therapy. Oncology nursing forum. 37(5). E349–E358. 17 indexed citations
6.
Nisman, Benjamin, Tanir M. Allweis, Luna Kaduri, et al.. (2010). Serum thymidine kinase 1 activity in breast cancer. Cancer Biomarkers. 7(2). 65–72. 34 indexed citations
7.
Harlap, Susan, Luna Kaduri, Ephrat Levy‐Lahad, et al.. (2007). Ethnic ancestry and increased paternal age are risk factors for breast cancer before the age of 40 years. European Journal of Cancer Prevention. 16(6). 549–554. 12 indexed citations
8.
Lotem, Michal, Eitan Shiloni, Itzhak Pappo, et al.. (2004). Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma. British Journal of Cancer. 90(4). 773–780. 24 indexed citations
9.
Nisman, Benjamin, Vivian Barak, Ayala Hubert, et al.. (2003). Prognostic factors for survival in metastatic breast cancer during first-line paclitaxel chemotherapy.. PubMed. 23(2C). 1939–42. 15 indexed citations
10.
Paltiel, Ora, Malka Avitzour, Tamar Peretz, et al.. (2001). Determinants of the Use of Complementary Therapies by Patients With Cancer. Journal of Clinical Oncology. 19(9). 2439–2448. 198 indexed citations
11.
Kaduri, Luna, Ayala Hubert, Michal Sagi, et al.. (1999). Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers. European Journal of Obstetrics & Gynecology and Reproductive Biology. 85(1). 75–80. 9 indexed citations
12.
Sagi, Michal, Luna Kaduri, Joël Zlotogora, & Tamar Peretz. (1998). The Effect of Genetic Counseling on Knowledge and Perceptions Regarding Risks for Breast Cancer. Journal of Genetic Counseling. 7(5). 417–434. 24 indexed citations
13.
Abeliovich, Dvorah, Luna Kaduri, Israela Lerer, et al.. (1997). The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.. PubMed. 60(3). 505–14. 296 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026